Vivos Primäre Funktion: Ophthalmochirurgisches System by Olcayto Guelec and David Geuder

Vivos Primäre Funktion: Ophthalmochirurgisches System by Olcayto Guelec and David Geuder is a highly esteemed winner of the very prestigious 2026 A' Design Award in Gold in Medizinproduktdesign Competition Category.

GoldMedizinprodukt· 2026

Vivos Primäre Funktion: Ophthalmochirurgisches System

by Olcayto Guelec and David Geuder

Client: Geuder AG

A' Design Award in Gold Winner in Medizinprodukt Category

53,358
Verified Award Winner
Verify Award Status for #182492

View at A' Design Award Press Release Award Badge

Colors

The Design

About Vivos Primäre Funktion: Ophthalmochirurgisches System

Buchtext: Vivos definiert die chirurgische Arbeitsstation neu – als Plattform, die sich gemeinsam mit den klinischen Ansprüchen weiterentwickelt. Drei Konfigurationen – Core, Nova und Nova+ – erweitern die Leistungsfähigkeit ohne Systemaustausch und bilden die einzige Upgrade-Architektur ihrer Art in der Augenchirurgie. Eine einheitliche Benutzeroberfläche, die mit 91,7 Prozent Zufriedenheit bei der ersten Nutzung ohne vorheriges Training validiert wurde, spiegelt ein Design wider, das sich am Chirurgen und nicht am Eingriff orientiert. Beleuchtete Instrumentenanschlüsse, hochwertige Materialien und eine zurückhaltende Detaillierung verleihen dem Gerät eine ruhige und selbstbewusste Präsenz, frei vom visuellen Lärm, der für diese Kategorie typisch ist.

The Recognition

About the A' Design Award in Gold

Vivos Primäre Funktion: Ophthalmochirurgisches System ist Gewinner des A' Design Award in Gold, einer überaus prestigeträchtigen Anerkennung für erstklassige, wunderbare und herausragende Designs. Gold-Gewinner sind äußerst innovative, visionäre und glamourös blendende Schöpfungen, die das Genie, die Weisheit und die Meisterschaft ihrer Designer widerspiegeln. Von Vivos Primäre Funktion: Ophthalmochirurgisches System wird erwartet, dass es eine hochgepriesene, trendsetzende und monumentale Erfindung ist, die beispiellosen Mehrwert liefert. Dieses mit dem A' Design Award in Gold prämierte Design ist ein spektakuläres, respektiertes Projekt, das den Grenzen von Kunst, Wissenschaft, Design und Technologie in hohem Maße zugutekommt und sie voranbringt. Vivos Primäre Funktion: Ophthalmochirurgisches System erzeugt intensive Gefühle des Verlangens, weckt Leidenschaft, ermutigt zur Kreativität und fasziniert uns.

Behind the Design

Press Kit

Credits, team members and technical details provided by the designer.

Unique Properties: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensions & Packaging: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Tags: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Production Technology: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Design Challenge: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Research: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiration: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Project Duration: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Operation Flow: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Team Members: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Image Credits: Photography Geuder AG, 2026